What does this TikTok creator claim?
@618109c says she lost only 10 pounds in one month on what appears to be a GLP-1 medication and lost all motivation to continue. The implication is that 10 pounds in 30 days represents poor results that aren't worth the effort.
She doesn't specify which GLP-1 drug she's taking or her starting dose. The video shows frustration with what she perceives as slow progress. This type of discouragement post gets hundreds of thousands of views because many people have unrealistic expectations about GLP-1 weight loss timelines.
Is 10 pounds in one month actually disappointing?
No, it's completely normal and actually on the higher end of expected early results. The STEP 1 trial (Wilding et al., NEJM, 2021) showed that participants on 2.4mg semaglutide lost an average of 2.6 pounds in the first four weeks.
Most people start GLP-1s at low doses like 0.25mg semaglutide or 2.5mg tirzepatide. You don't reach therapeutic doses for months. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found tirzepatide users lost just 1.9% of body weight in the first month.
Ten pounds in 30 days means this creator is responding well to treatment. Her expectations, not her results, are the problem.
What does realistic GLP-1 weight loss look like?
The major trials show a clear pattern: slow starts, accelerating losses, then plateau around 60-68 weeks. In STEP 1, participants reached maximum weight loss at 68 weeks with 14.9% total body weight reduction.
SURMOUNT-1 showed even better results with tirzepatide's highest dose (15mg) leading to 20.9% weight loss over 72 weeks. But month one? Barely noticeable changes for most people.
The drug manufacturers design this slow escalation on purpose. Starting with low doses reduces nausea and vomiting that can force people to quit treatment entirely.
What's driving these unrealistic expectations?
Social media posts about dramatic rapid weight loss create false benchmarks. You'll see before-and-after photos spanning months presented as if they happened quickly.
The reality is that GLP-1 medications work by slowing gastric emptying and reducing appetite through brain receptors. These mechanisms take time to show their full effects, especially as doses gradually increase.
Sustainable weight loss of 1-2 pounds per week is considered ideal by obesity medicine specialists. @618109c actually exceeded that target but still felt disappointed.
Should she really give up after one month?
Absolutely not. Stopping GLP-1 treatment after 30 days means missing the entire therapeutic benefit window. Most clinical trials don't even measure primary endpoints until 68-72 weeks for good reason.
The STEP 2 trial (Davies et al., NEJM, 2021) found that people with diabetes lost 9.6% of body weight over 68 weeks on semaglutide. Quitting at month one would mean missing 90% of potential results.
Weight loss plateaus are normal and don't indicate treatment failure. Dose adjustments and lifestyle modifications can restart progress when combined with continued medication use.